Drug-Discovery

An extensive analysis comparing costs of animal research vs NAM across micro and macro economics.

Chief Scientific Officer at Emulate, Inc, pioneering organ-on-a-chip technology.

An expert in computational drug design and molecular pharmacology.

Leading businesses utilizing and advancing NAM technologies.

AI analysis of vast datasets accelerate drug discovery through identification, prediction, and repurposing.

Legacy animal research costs up to $2.6B per pipeline asset vs NAM’s streamlined, human-predictive framework.